Search Results - "Nurden, A."

Refine Results
  1. 1

    Advances in our understanding of the molecular basis of disorders of platelet function by NURDEN, A., NURDEN, P.

    Published in Journal of thrombosis and haemostasis (01-07-2011)
    “…Genetic defects of platelet function give rise to mucocutaneous bleeding of varying severity because platelets fail to fulfil their haemostatic role after…”
    Get full text
    Journal Article
  2. 2

    Inherited disorders of platelet function: selected updates by Nurden, A. T., Nurden, P.

    Published in Journal of thrombosis and haemostasis (01-06-2015)
    “…Summary The gene variants responsible for the primary genotype of many platelet disorders have now been identified. Next‐generation sequencing technology…”
    Get full text
    Journal Article
  3. 3

    Inherited platelet disorders by NURDEN, A. T., FRESON, K., SELIGSOHN, U.

    “…Inherited diseases of the megakaryocyte lineage give rise to bleeding when platelets fail to fulfill their hemostatic function upon vessel injury. Platelet…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey by Gresele, P., Harrison, P., Bury, L., Falcinelli, E., Gachet, C., Hayward, C. P., Kenny, D., Mezzano, D., Mumford, A. D., Nugent, D., Nurden, A. T., Orsini, S., Cattaneo, M.

    Published in Journal of thrombosis and haemostasis (01-09-2014)
    “…Summary Background Diagnosis of inherited platelet function disorders (IPFDs) is important for appropriate management and to improve epidemiologic and clinical…”
    Get full text
    Journal Article
  6. 6

    Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients by Anitua, E., Sánchez, M., Nurden, A. T., Zalduendo, M. M., de la Fuente, M., Azofra, J., Andía, I.

    Published in Rheumatology (Oxford, England) (01-12-2007)
    “…Objectives. Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in osteoarthritis (OA) capsular joints via multiple mechanisms. Our…”
    Get full text
    Journal Article
  7. 7

    Qualitative disorders of platelets and megakaryocytes by NURDEN, A. T.

    Published in Journal of thrombosis and haemostasis (01-08-2005)
    “…Qualitative disorders of platelet function and production form a large group of rare diseases which cover a multitude of genetic defects that by and large have…”
    Get full text
    Journal Article
  8. 8
  9. 9

    An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families by Matus, V., Valenzuela, G., Sáez, C. G., Hidalgo, P., Lagos, M., Aranda, E., Panes, O., Pereira, J., Pillois, X., Nurden, A. T., Mezzano, D.

    Published in Journal of thrombosis and haemostasis (01-09-2013)
    “…Summary Background Glycoprotein VI (GPVI), 60–65 kDa, is a major collagen receptor on platelet membranes involved in adhesive and signaling responses. Mice…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The abnormal proplatelet formation in MYH9‐related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition by Chen, Y., Boukour, S., Milloud, R., Favier, R., Saposnik, B., Schlegel, N., Nurden, A., Raslova, H., Vainchenker, W., Balland, M., Nurden, P., Debili, N.

    Published in Journal of thrombosis and haemostasis (01-12-2013)
    “…Summary Background Mutations in the MYH9 gene cause autosomal dominant MYH9‐related diseases (MYH9‐RD) that associate macrothrombocytopenia with various other…”
    Get full text
    Journal Article
  12. 12

    Natural history of platelet antibody formation against αIIbβ3 in a French cohort of Glanzmann thrombasthenia patients by FIORE, M., FIRAH, N., PILLOIS, X., NURDEN, P., HEILIG, R., NURDEN, A. T.

    “…Treatment of the bleeding syndrome in Glanzmann thrombasthenia (GT) is often complicated by naturally occurring isoantibodies directed against the αIIbβ3…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis by NURDEN, P., TANDON, N., TAKIZAWA, H., COUZI, L., MOREL, D., FIORE, M., PILLOIS, X., LOYAU, S., JANDROT‐PERRUS, M., NURDEN, A. T.

    Published in Journal of thrombosis and haemostasis (01-09-2009)
    “…Background: GPVI is a major platelet collagen signaling receptor. In rare cases of immune thrombocytopenic purpura (ITP), autoantibodies to GPVI result in…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Use of autologous platelet-rich clots for the prevention of local injury bleeding in patients with severe inherited mucocutaneous bleeding disorders by NURDEN, P., YOULOUZ-MARFAK, I., SIBERCHICOT, F., KOSTRZEWA, E., ANDIA, I., ANITUA, E., NURDEN, A. T.

    “…Stopping or preventing local bleeding in patients with inherited bleeding disorders linked to abnormal platelet function is traditionally treated by…”
    Get full text
    Journal Article
  18. 18

    Altered megakaryocytopoiesis in von Willebrand type 2B disease by NURDEN, A. T., FEDERICI, A. B., NURDEN, P.

    Published in Journal of thrombosis and haemostasis (01-07-2009)
    “…Type 2B von Willebrand disease (VWD2B) is caused by gain‐of‐function amino acid substitutions in the von Willebrand factor (VWF) A1 domain. These allow…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance by Nurden, A T

    Published in Thrombosis and haemostasis (01-07-1995)
    “…The haemostatic response of platelets of any one individual will be influenced by the genetic profile of the total population of receptors expressed on the…”
    Get more information
    Journal Article